Zura Bio Ltd (NASDAQ:ZURA) shares, rose in value on Wednesday, June 18, with the stock price down by -2.63% to the previous day’s close as strong demand from buyers drove the stock to $1.11.
Actively observing the price movement in the last trading, the stock closed the session at $1.14, falling within a range of $1.1 and $1.1499. The value of beta (5-year monthly) was -0.129. Referring to stock’s 52-week performance, its high was $5.07, and the low was $0.97. On the whole, ZURA has fluctuated by 2.78% over the past month.
With the market capitalization of Zura Bio Ltd currently standing at about $68.68 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ZURA’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of ZURA currently trading nearly -1.10% and -8.41% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 43.71, while the 7-day volatility ratio is showing 2.15% which for the 30-day chart, stands at 3.99%. Furthermore, Zura Bio Ltd (ZURA)’s beta value is -0.12, and its average true range (ATR) is 0.10.
A comparison of Zura Bio Ltd (ZURA) with its peers suggests the former has fared considerably weaker in the market. ZURA showed an intraday change of -2.63% in last session, and over the past year, it shrunk by -70.56%%.
Data on historical trading for Zura Bio Ltd (NASDAQ:ZURA) indicates that the trading volumes over the past 10 days have averaged 0.53 and over the past 3 months, they’ve averaged 461.50K. According to company’s latest data on outstanding shares, there are 68.37 million shares outstanding.
Nearly 37.57% of Zura Bio Ltd’s shares belong to company insiders and institutional investors own 61.09% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.08 million shares as on 2025-05-30, resulting in a short ratio of 5.85. According to the data, the short interest in Zura Bio Ltd (ZURA) stood at 551.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 2.49 million. The stock has fallen by -55.60% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ZURA stock heading into the next quarter.
